Macrogenics Newsroom

H.C. Wainwright Maintains Macrogenics(MGNX.US) With Hold Rating, Cuts Target Price to $2

Moomoo NewsMar 26 02:31 ET

Macrogenics Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesMar 25 07:19 ET

Macrogenics Analyst Ratings

BenzingaMar 25 07:09 ET

MacroGenics: Hold Rating Amidst Development Halts and Financial Challenges

TipRanksMar 25 06:28 ET

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)

TipRanksMar 24 20:54 ET

Stifel Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $6

Moomoo NewsMar 22 02:32 ET

Barclays Maintains Macrogenics(MGNX.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsMar 21 05:31 ET

Barclays Sticks to Their Buy Rating for MacroGenics (MGNX)

TipRanksMar 21 03:43 ET

TD Cowen Maintains Macrogenics(MGNX.US) With Hold Rating

Moomoo NewsMar 21 02:32 ET

JMP Securities Maintains Macrogenics(MGNX.US) With Hold Rating

Moomoo NewsMar 21 02:32 ET

JMP Securities Maintains Macrogenics(MGNX.US) With Hold Rating

Moomoo NewsNov 8, 2024 04:33 ET

MacroGenics Downgraded to Market Perform by JMP, Price Target Removed

Seeking AlphaNov 7, 2024 10:52 ET

A Quick Look at Today's Ratings for Macrogenics(MGNX.US), With a Forecast Between $4 to $8

Moomoo NewsNov 7, 2024 08:09 ET

MacroGenics (MGNX) Was Downgraded to a Hold Rating at JMP Securities

TipRanksNov 7, 2024 00:42 ET

MacroGenics' Strategic Moves and Promising Pipeline Justify Buy Rating

TipRanksNov 6, 2024 11:17 ET

Macrogenics Analyst Ratings

BenzingaNov 6, 2024 07:25 ET

H.C. Wainwright Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $4

Moomoo NewsNov 6, 2024 06:31 ET

Balanced Hold Rating Reflects Cautious Optimism and Strategic Risks for MacroGenics

TipRanksNov 6, 2024 06:28 ET

Barclays Maintains Macrogenics(MGNX.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 6, 2024 03:31 ET

TD Cowen Maintains Macrogenics(MGNX.US) With Hold Rating

Moomoo NewsNov 5, 2024 19:32 ET